The purpose of the Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB) is to facilitate the transition of innovative cardiovascular technologies from idea to clinical implementation, whilst also investigating the clinical challenges facing existing technology.
| Website | http://www.icetlab.com |
| Revenue | $5 million |
| Employees | 2 (2 on RocketReach) |
| Address | Clinical Sciences Building, The Prince Charles Hospital, Brisbane, Queensland 4032, AU |
| Industry | Research Services, Business Services General, Business Services |
| Keywords | Health Tech, Medtech, Cardiovascular Technology, Innovation Lab, Medical Device Development, Innovative Technology, Biomedical Engineering, Cardiology Research, Healthcare Technology, Medical Innovation, Technology Transfer, Vascular Technology, Medical Research, Clinical Trials, Surgical Innovation, Device Innovation, Therapeutic Devices, Cardiovascular Devices |
| Competitors | Deloitte, IBM, Accenture, Wipro, Tata Consultancy Services, Capgemini, Infosys, HP, Capita, Cognizant Softvision +52 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular ICETLAB employee's phone or email?
The ICETLAB annual revenue was $5 million in 2026.
2 people are employed at ICETLAB.
ICETLAB is based in Brisbane, Queensland.
The NAICS codes for ICETLAB are [541, 5417, 54].
The SIC codes for ICETLAB are [87, 873].